Retraction
MicroRNA‑126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial‑to‑mesenchymal transition and ERK/MAPK signaling pathway
Paper Information
Record ID:
54789
Author(s):
Journal:
Publication Date:
May 29, 2020
Retraction Date:
July 01, 2024
(1.4 year years ago)
Subjects:
Institutions:
- Reproductive Medicine Centre, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China
- Department of Obstetrics and Gynecology, Zhangqiu District Maternal and Child Health Care Hospital, Jinan, Shandong 250200, P.R. China
- Department of Nursing, The Third People's Hospital of Qingdao, Qingdao, Shandong 266041, P.R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (18)
18
Total Citations6
Post-Retraction(33.3%)
12
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
6
Within 1 year
0
After 2+ years
365
Days since retraction (latest)
MicroRNA-126: A key regulator of angiogenesis, inflammation, and tumorigenesis — Exploring its multifaceted functions in vascular health and cancer
Oliwia Woźniak, Bartosz Mierzejewski, Edyta Brzóska
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Published: Jul 2025
365 days after retraction
miR-126: a bridge between cancer and exercise
Zhengqiong Liu, Shanbin Ke, Yi Wan
Cancer Cell International
Open Access
Published: Apr 2025
288 days after retraction
Emerging roles of EGFL family members in neoplastic diseases: Molecular mechanisms and targeted therapies
Xiaoge Gao, Guopeng Zhang, Feitong Wang et al. (7 authors)
Biochemical Pharmacology
Published: Mar 2025
246 days after retraction
Suppression of KLF5 targets RREB1 to restrain the proliferation of ovarian cancer cells through ERK/MAPK signaling pathway
Shenglan Wang, Chuanchuan Liu, Yongchuan Li et al. (8 authors)
3 Biotech
Published: Dec 2024
163 days after retraction
AOPPs induces EMT and fibrosis by activating oxidative stress through ERK/p38 MAPK signaling pathway in endometriosis
Xiaoqing Luo, Sixi Wen, Jun-ling Zeng et al. (16 authors)
Reproductive Biology
Open Access
Published: Sep 2024
4 citations
4 citations
67 days after retraction
Prognostic Significance of Non-Coding RNAs Related to the Tumorigenic Epithelial-Mesenchymal Transition (EMT) Process Among Ovarian Cancer Patients: A Systematic Review and Meta-Analysis
Alireza Soltani Khaboushan, Seyedeh Nazanin Salimian, Saghar Mehraban et al. (8 authors)
Heliyon
Open Access
Published: Aug 2024
1 citation
1 citation
31 days after retraction
HER2 puzzle pieces: Non-Coding RNAs as keys to mechanisms, chemoresistance, and clinical outcomes in Ovarian cancer
Fangwei Yang, Lixiang Yan, Junnan Ji et al. (5 authors)
Pathology - Research and Practice
Published: Apr 2024
1 citation
1 citation
63 days before retraction
Endometriosis and the risk of ovarian cancer: is miR126 the Achille’s heel?
Raffaella Mormile
Archives of Gynecology and Obstetrics
Published: Feb 2024
125 days before retraction
Role of EGFL7 in human cancers: A review
Cristiane de Oliveira, Paola Gyuliane Gonçalves, Lucas Tadeu Bidinotto
Journal of Cellular Physiology
Open Access
Published: Jul 2023
3 citations
3 citations
342 days before retraction
Hepatocellular carcinoma cells remodel the pro-metastatic tumour microenvironment through recruitment and activation of fibroblasts via paracrine Egfl7 signaling
Bo Sun, Xiong Lei, Momo Cao et al. (5 authors)
Cell Communication and Signaling
Open Access
Published: Jul 2023
6 citations
6 citations
346 days before retraction
The emerging role of microRNA-126 as a potential therapeutic target in cancer: a comprehensive review
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Lubna R. Al-Ameer et al. (7 authors)
Pathology - Research and Practice
Open Access
Published: Jun 2023
20 citations
20 citations
377 days before retraction
MicroRNA-211 Regulates Proliferation, Expansion, and Immune Inhibitory Function of Myeloid-Derived Suppressor Cells via Mediation of CHOP Expression
Lie Zheng, Min Huang, Yuhong Ye et al. (4 authors)
Immunological Investigations
Open Access
Published: Jun 2023
4 citations
4 citations
384 days before retraction
MicroRNA‑126 expression in the peripheral white blood cells of patients with breast and ovarian cancer is a potential biomarker for the early prediction of cancer risk in the carriers of methylated <i>BRCA1</i>
Maram Al‐Showimi, Nujoud Al‐Yousef, Wejdan Alharbi et al. (8 authors)
Oncology Letters
Open Access
Published: Jun 2022
7 citations
7 citations
740 days before retraction
LncRNA CRNDE promotes cell proliferation, migration and invasion of ovarian cancer via miR-423-5p/FSCN1 axis
Qiong Wang, Lingxiong Wang, Chunyan Zhang et al. (8 authors)
Molecular and Cellular Biochemistry
Published: Feb 2022
27 citations
27 citations
867 days before retraction
Polydopamine Nanoparticles Loaded with EPB41L4A-AS2 Promote Ovarian Cancer Cell Apoptosis Through Activation of Mitogen-Activated Protein Kinase Signaling Pathway
Xiaoying Wu, Xuefeng Xing, Ming An
Science of Advanced Materials
Published: Feb 2022
3 citations
3 citations
881 days before retraction
ARHGEF19 promotes the growth of breast cancer in vitro and in vivo by the MAPK pathway
Ligang Niu, Yuhui Zhou, Wei Zhang et al. (5 authors)
Physiology International
Open Access
Published: Nov 2021
2 citations
2 citations
951 days before retraction
Epidermal growth factor-like domain 7 regulates breast cancer cell proliferation and vascular endothelial growth factor expression via the p38MAPK signaling pathway
Bei Zhou, Jing Wang
American Journal of Translational Research
Published: Apr 2021
5 citations
5 citations
1173 days before retraction
MiR-126 Suppresses Colitis-Associated Colorectal Cancer by Regulating Crosstalk Between Epithelium Cells and Macrophages via CXCL12
Shuai Wu, Wei Yuan, Weiwei Luo et al. (6 authors)
Research Square (Research Square)
Open Access
Published: Dec 2020
1 citation
1 citation
1281 days before retraction
Quick Stats
Total Citations:
18
Years Since Retraction:
1.4 year
Open Access:
Yes
Last Checked:
Jul 24, 2025